← back to database
The AMR Action Fund is a global life-sciences specialist dedicated to developing urgently needed antibiotics and antifungals against antimicrobial resistance. Backed by biopharmaceutical companies, foundations and development banks, it targets more than $1 billion of investment and aims to help bring two to four new antimicrobial therapies to patients by 2030.
Lead / follow
Specialization
Generalist / Specialist
Specialist
Latest fund size
$1B+ target
Latest fund vintage
2020
Investing team
Carly LevineSenior Associate
Henni-Karoliina RopponenVenture Associate
Henry SkinnerChief Executive Officer
Isabella SantiVenture Associate
Junjun GaoPrincipal
Martin HeideckerChief Investment Officer
How to reach them
Notable investments
F2G, BioVersys, Vedanta Biosciences, Antabio, Peptilogics, Centauri Therapeutics, TenNor Therapeutics, Telum Therapeutics, Trellis Bioscience, Elion Therapeutics